Log in
Enquire now
‌

US Patent 8067546 Humanized anti-CD70 binding agents and uses thereof

Patent 8067546 was granted and assigned to Seagen on November, 2011 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Seagen
Seagen
0
Date Filed
April 19, 2006
0
Date of Patent
November 29, 2011
0
Patent Application Number
11912096
0
Patent Citations Received
‌
US Patent 11965180 Cancer stem cell population and method for production thereof
0
‌
US Patent 11786604 Compounds and compositions for treating HER2 positive tumors
‌
US Patent 11834448 2-amino-quinoline derivatives
0
Patent Inventor Names
Paul Carter
0
Che-Leung Law
0
Julie McEarchern
0
Charlotte McDonagh
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8067546
0
Patent Primary Examiner
‌
Anne M. Gussow
0

Find more entities like US Patent 8067546 Humanized anti-CD70 binding agents and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.